The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and provides ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Alvotech ( ($ALVO) ) has issued an update. On November 2, 2025, Alvotech announced that the U.S. FDA issued a complete response letter for its ...

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...

LBS Centre for Science and Technology; Palayam, Nandavanam, has invited applications for the State Eligibility Test (SET), January 2026. SET is an eligibility test for selection as higher secondary ...

| Build smarter healthcare apps, faster. See how clinical data repositories help developers unlock clinical data and drive ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an ...

The Department of Biotechnology is creating regional innovation hubs and 'Bio E3 Cells' to build a stronger national ...

Since 2019, breakthroughs in synthetic biology, AI-driven protein design, and precision fermentation have revitalized the ...